In the biotech and IT companies, majority of the researchers (PhD.) are foreigners who need the OPT extension to apply H1B lottery which is abused by ICC companies. There is Cap of H1B each year and a lot of ICC companies apply multiple H1B for one person, so the chance to get the H1B is very small now. In R&D area which requires PhD, it is very hard to hire qualified Americans with citizenship, so high degree foreigners is in great demand. To keep the most talent people in this country, OPT extension is very helpful since it will increase the chance to get an H1B.